Quest Laborato.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0TNW01017
  • NSEID: QUESTLAB
  • BSEID:
INR
110.20
0.2 (0.18%)
BSENSE

Mar 05

BSE+NSE Vol: 6000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Standalone Nine Monthly Results
Dec'25
Dec'24
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 38.18% vs -19.77% in Dec 2024

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 47.09% vs -20.19% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 24.80% vs -30.69% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is 212.96% vs -31.65% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024

Compare Nine Monthly Results Of Quest Laborato. With
Markets Mojo
Figures in Cr
Standalone Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
79.41
63.37
16.04
25.31%
Other Operating Income
0.00
0.00
0.00
Total Operating income
79.41
63.37
16.04
25.31%
Raw Material Cost
64.28
63.79
0.49
0.77%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-4.71
-4.86
0.15
3.09%
Employee Cost
3.30
5.93
-2.63
-44.35%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
11.43
-11.43
-100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
2.45
2.57
-0.12
-4.67%
Total Expenditure (Excl Depreciation)
65.32
78.86
-13.54
-17.17%
Operating Profit (PBDIT) excl Other Income
14.09
-15.49
29.58
190.96%
Other Income
3.84
0.11
3.73
3,390.91%
Operating Profit (PBDIT)
17.93
-15.38
33.31
216.58%
Interest
1.69
2.97
-1.28
-43.10%
Exceptional Items
0.00
-0.01
0.01
100.00%
Gross Profit (PBDT)
16.24
-18.36
34.60
188.45%
Depreciation
0.61
2.56
-1.95
-76.17%
Profit Before Tax
15.64
-20.92
36.56
174.76%
Tax
3.50
-5.03
8.53
169.58%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
12.15
-15.88
28.03
176.51%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
12.15
-15.88
28.03
176.51%
Equity Capital
16.39
36.98
-20.59
-55.68%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.00
0.00
0.00
Operating Profit Margin (Excl OI)
17.74%
-24.44%
0.00
42.18%
Gross Profit Margin
20.45%
-28.97%
0.00
49.42%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 79.41 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 38.18% vs -19.77% in Dec 2024

Nine Monthly - Standalone Net Profit
Standalone Net Profit 12.15 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 47.09% vs -20.19% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.09 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 24.80% vs -30.69% in Dec 2024

Nine Monthly - Interest
Interest 1.69 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 212.96% vs -31.65% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.74%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024